Browse by Medical Category
CEDD home page
The MGH Psychiatry Center for Experimental Drugs & Diagnostics is dedicated to finding new and effective treatments through safe and personalized clinical trials. Our clinicians are highly experienced, and we use the latest technology in our research. We are dedicated to identifying new treatments for psychiatric disorders and bringing them to patients.
Interested in research participation? We are currently recruiting patients diagnosed with a variety of neuropsychiatric disorders, including depression, bipolar disorder, and schizophrenia. Please call Leslie at 617-643-3105 or email CEDD@partners.org to see if you might be eligible to participate in a study.
The purpose of this research study is to collect, process and store samples to do research on neuropsychiatric disorders. This research study looks at changes in the human body associated with neuropsychiatric disorders. Part of this study involves the collection of skin and blood samples that will be stored in a tissue bank for later use. Research using these samples will attempt to identify causes and what helps prevent, treat, or cure neuropsychiatric disorders. In addition, the samples collected for this study will be used for genetic research on these diseases.
If you are interested in this study please contact the research coordinator at (617) 643-3105 or CEDD@partners.org
Current and past CEDD studies are supported by funding from NIMH, NARSAD, the National Science Foundation, AHRQ, the Stanley Center for Psychiatric Research at the Broad Institute, the American Philosophical Society, the Bowman Family Foundation, and the Sidney J. Baer, Jr. Foundation, as well as by industry partners including Proteus Biomedical.
Back to Top